Legal Disclaimer & Statutory Notice
Last revised: November 2026
FDAcleared.org is an independent, privately operated research tool. It is NOT affiliated with, sponsored by, or endorsed by the U.S. Food and Drug Administration (FDA) or the Department of Health and Human Services (HHS).
1. Strict Non-Affiliation Declaration
FDAcleared.org is an independent competitive research and data aggregation platform operated independently. It is NOT affiliated with, sponsored by, endorsed by, certified by, or officially connected in any manner with the U.S. Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), or any other agency, authority, or branch of the United States Government.
The official website of the U.S. Food and Drug Administration can be accessed at www.fda.gov.
2. Public Domain Data Attribution
The records presented on this platform are aggregated from publicly available federal government databases provided by the FDA via the openFDA API (api.fda.gov) and FDA AccessData database servers. Works of the United States Government are not subject to copyright protection under Title 17, Section 105 of the United States Code.
3. Express "AS IS" Warranty Disclaimer
ALL DATA, SEARCH RESULTS, CONTACTS, REPUTED MARKET STATUSES, AND REGULATORY DESIGNATIONS ARE PROVIDED SOLELY ON AN "AS IS" AND "AS AVAILABLE" BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED.
FDAcleared.org makes no representations or warranties regarding accuracy, completeness, reliability, timeliness, non-infringement, or fitness for any particular purpose. Upstream FDA records may contain clerical data entry errors, delayed updates, or retroactive amendments. Users must verify all primary records via the official FDA AccessData backlinks provided on each device record.
4. Not Legal, Regulatory, or Medical Advice
The content available on FDAcleared.org is for informational, research, and competitive intelligence purposes only. It does NOT constitute legal counsel, regulatory advice, predicate device qualification, compliance auditing, medical diagnosis, or treatment recommendations. Individuals or corporations preparing FDA submissions (510(k), De Novo, PMA) must consult qualified regulatory affairs (RA/QA) professionals, attorneys, and official FDA guidance documents.
5. Statutory Terminology Compliance (21 CFR § 807.97)
Under Title 21 of the Code of Federal Regulations § 807.97, an FDA 510(k) clearance does not constitute an "approval" of a medical device. Marketing or representing a 510(k)-cleared device as "FDA Approved" is considered misleading under federal law. This platform strictly enforces statutory accuracy by differentiating "FDA Cleared" (Substantial Equivalence under 21 CFR § 807) from "FDA Approved" (Premarket Approval under Section 515 of the FD&C Act) and "De Novo Granted" (Section 513(f)(2)).
6. Securities & Financial Intelligence
Company classifications (Public, Private, Subsidiary), stock tickers, and SEC CIK references are enriched using public SEC EDGAR filings and curated heuristics. They are provided for identification and B2B research purposes only and do NOT constitute investment advice or solicitation of securities.
7. Data Inaccuracy & Error Reporting
If you identify an inaccurate company classification, incorrect contact attribution, or clerical error on a device record, please contact our research team at support@fdacleared.org. Validated corrections are investigated and updated promptly in our synchronization pipeline.